STELLIAM INVESTMENT MANAGEMENT, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
STELLIAM INVESTMENT MANAGEMENT, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$15,642,000
+71.3%
640,000
+81.8%
3.24%
+43.7%
Q4 2018$9,133,000
-44.2%
352,100
-32.0%
2.25%
+157.1%
Q3 2018$16,379,000
+185.8%
517,500
+250.8%
0.88%
+231.8%
Q2 2018$5,730,000
-34.5%
147,500
-53.5%
0.26%
-27.9%
Q1 2018$8,749,000317,0000.37%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders